Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

CF and non-CF bronchiectasis

  • Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
    Laura K. Fawcett, Claire E. Wakefield, Sheila Sivam, Peter G. Middleton, Peter Wark, John Widger, Adam Jaffe, Shafagh A. Waters
    ERJ Open Research Jan 2021, 7 (1) 00448-2020; DOI: 10.1183/23120541.00448-2020
  • Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
    Grace Y. Lam, Jodi Goodwin, Pearce G. Wilcox, Bradley S. Quon
    ERJ Open Research Jan 2021, 7 (1) 00475-2020; DOI: 10.1183/23120541.00475-2020
  • Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia
    Alex Gileles-Hillel, Hagar Mor-Shaked, David Shoseyov, Joel Reiter, Reuven Tsabari, Avigdor Hevroni, Malena Cohen-Cymberknoh, Israel Amirav, Shuli Brammli-Greenberg, Amjad Horani, Eitan Kerem, Oded Breuer
    ERJ Open Research Oct 2020, 6 (4) 00213-2020; DOI: 10.1183/23120541.00213-2020
  • Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis
    Peter Nickolaus, Birgit Jung, Juan Sabater, Samuel Constant, Abhya Gupta
    ERJ Open Research Oct 2020, 6 (4) 00429-2020; DOI: 10.1183/23120541.00429-2020
  • An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CFTM 1
    Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac
    ERJ Open Research Oct 2020, 6 (4) 00395-2020; DOI: 10.1183/23120541.00395-2020
  • Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis
    Tobias Engel, Paul E. Verweij, Joost van den Heuvel, Dechen Wangmo, Jianhua Zhang, Alfons J.M. Debets, Eveline Snelders
    ERJ Open Research Oct 2020, 6 (4) 00020-2020; DOI: 10.1183/23120541.00020-2020
  • Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review
    Melissa J. McDonnell, Eoin B. Hunt, Chris Ward, Jeffrey P. Pearson, Daniel O'Toole, John G. Laffey, Desmond M. Murphy, Robert M. Rutherford
    ERJ Open Research Oct 2020, 6 (4) 00190-2019; DOI: 10.1183/23120541.00190-2019
  • Comparison of ciliary beat frequencies at different temperatures in young adults
    Wilfried Nikolaizik, Jana Hahn, Monika Bauck, Stefanie Weber
    ERJ Open Research Oct 2020, 6 (4) 00477-2020; DOI: 10.1183/23120541.00477-2020
  • Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases
    Mirjam Stahl, Cornelia Joachim, Ines Kirsch, Tatjana Uselmann, Yin Yu, Nadine Alfeis, Christiane Berger, Rebecca Minso, Isa Rudolf, Cornelia Stolpe, Xenia Bovermann, Lena Liboschik, Alena Steinmetz, Dunja Tennhardt, Friederike Dörfler, Jobst Röhmel, Klaudia Unorji-Frank, Claudia Rückes-Nilges, Bianca von Stoutz, Lutz Naehrlich, Matthias V. Kopp, Anna-Maria Dittrich, Olaf Sommerburg, Marcus A. Mall
    ERJ Open Research Oct 2020, 6 (4) 00408-2020; DOI: 10.1183/23120541.00408-2020
  • Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
    Silke van Koningsbruggen-Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut Smerud, Nils Meland, Jann Mortensen, Marie Ø. Fosbøl, Damian G. Downey, Astrid H. Myrset, Hugo Flaten, Philip D. Rye
    ERJ Open Research Oct 2020, 6 (4) 00132-2020; DOI: 10.1183/23120541.00132-2020

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 13
  • Acute lung injury and critical care (39)
  • Asthma and allergy (192)
  • CF and non-CF bronchiectasis (121)
  • COPD and smoking (304)
  • Epidemiology, occupational and environmental lung disease (54)
  • Genetics (25)
  • Interstitial and orphan lung disease (151)
  • Lung biology and experimental studies (76)
  • Lung cancer (67)
  • Lung imaging (47)
  • Lung structure and function (95)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (99)
  • Pulmonary pharmacology and therapeutics (113)
  • Pulmonary vascular disease (72)
  • Respiratory clinical practice (85)
  • Respiratory infections and tuberculosis (287)
  • Sleep medicine (46)
  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
  • International consensus on lung function testing during the COVID-19 pandemic and beyond
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society